- Learn the basics
- Find stocks
- Understand a stock
Alpha Cognition Inc.
ACOG United States NASDAQAlpha Cognition Inc. is a clinical-stage biopharmaceutical company focused on the development of therapeutics for neurodegenerative diseases. The Company’s operations consist of a single segment dedicated to research, clinical development, and regulatory activities related to its product candidates. Its lead product candidate, ALPHA-1062, is an oral tablet formulation of a prodrug of galantamine intended for the treatment of mild-to-moderate Alzheimer’s disease. The Company is also developing ALPHA-0602, a granulocyte colony-stimulating factor for potential use in amyotrophic lateral sclerosis and other neurodegenerative indications. Alpha Cognition conducts its activities primarily in North America and targets the pharmaceutical markets for Alzheimer’s disease and related neurodegenerative conditions.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company and how factual it is. What the ratings mean.